Arquer Diagnostics, a Sunderland-based company focused on the development of non-invasive cancer diagnostics tests, has secured £1.8m, which will help in finishing its international clinical trial and commercialising its bladder cancer kit test kit across the globe. The diagnostic kit is based on the detection of minichromosome maintenance proteins (MCM5) in the urine, which indicate…
Read more
Arquer Diagnostics becomes North East Fund’s 100th investment
